A detailed history of Ensign Peak Advisors, Inc transactions in Moderna, Inc. stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 68,589 shares of MRNA stock, worth $2.76 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
68,589
Previous 73,064 6.12%
Holding current value
$2.76 Million
Previous $8.68 Million 47.18%
% of portfolio
0.01%
Previous 0.02%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$63.64 - $125.14 $284,789 - $560,001
-4,475 Reduced 6.12%
68,589 $4.58 Million
Q2 2024

Aug 13, 2024

SELL
$101.21 - $166.61 $8.12 Million - $13.4 Million
-80,198 Reduced 52.33%
73,064 $8.68 Million
Q1 2024

May 14, 2024

BUY
$85.37 - $115.44 $4.81 Million - $6.51 Million
56,350 Added 58.15%
153,262 $16.3 Million
Q4 2023

Feb 14, 2024

BUY
$69.51 - $104.43 $1.02 Million - $1.54 Million
14,735 Added 17.93%
96,912 $9.64 Million
Q3 2023

Nov 13, 2023

BUY
$96.41 - $126.61 $3.87 Million - $5.09 Million
40,185 Added 95.7%
82,177 $8.49 Million
Q2 2023

Aug 14, 2023

SELL
$118.5 - $160.53 $12.7 Million - $17.2 Million
-107,060 Reduced 71.83%
41,992 $5.1 Million
Q1 2023

May 15, 2023

BUY
$135.66 - $197.02 $3.95 Million - $5.74 Million
29,110 Added 24.27%
149,052 $22.9 Million
Q4 2022

Feb 13, 2023

BUY
$118.38 - $210.04 $7.5 Million - $13.3 Million
63,368 Added 112.01%
119,942 $21.5 Million
Q3 2022

Nov 14, 2022

SELL
$118.07 - $194.18 $5.3 Million - $8.72 Million
-44,905 Reduced 44.25%
56,574 $6.69 Million
Q2 2022

Aug 12, 2022

BUY
$117.13 - $176.59 $570,423 - $859,993
4,870 Added 5.04%
101,479 $14.5 Million
Q1 2022

May 16, 2022

BUY
$126.46 - $235.05 $6.9 Million - $12.8 Million
54,600 Added 129.97%
96,609 $16.6 Million
Q4 2021

Feb 11, 2022

SELL
$225.82 - $368.51 $8.55 Million - $13.9 Million
-37,848 Reduced 47.39%
42,009 $10.7 Million
Q3 2021

Nov 12, 2021

BUY
$221.9 - $484.47 $14.5 Million - $31.7 Million
65,392 Added 452.07%
79,857 $30.7 Million
Q2 2021

Aug 13, 2021

SELL
$129.91 - $234.98 $1.8 Million - $3.25 Million
-13,845 Reduced 48.9%
14,465 $3.4 Million
Q1 2021

May 12, 2021

SELL
$109.18 - $185.98 $571,775 - $973,977
-5,237 Reduced 15.61%
28,310 $3.71 Million
Q4 2020

Feb 12, 2021

SELL
$65.74 - $169.86 $2.77 Million - $7.16 Million
-42,148 Reduced 55.68%
33,547 $3.5 Million
Q3 2020

Nov 12, 2020

BUY
$54.34 - $94.85 $998,497 - $1.74 Million
18,375 Added 32.06%
75,695 $5.36 Million
Q2 2020

Aug 12, 2020

BUY
$29.67 - $80.0 $1.7 Million - $4.59 Million
57,320 New
57,320 $3.68 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $15.8B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Ensign Peak Advisors, Inc Portfolio

Follow Ensign Peak Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.